Pharmacogenetic Profile and Major Depressive and/or Bipolar Disorder Treatment: a Retrospective, Cross-Sectional Study
Author(s) -
Theresa R. Tonozzi,
Glenn D. Braunstein,
Anja Kammesheidt,
Chris Curran,
Shahrokh Golshan,
John R. Kelsoe
Publication year - 2018
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs-2018-0088
Subject(s) - pharmacogenetics , cross sectional study , bipolar disorder , medicine , retrospective cohort study , psychiatry , lithium (medication) , genotype , biology , genetics , gene , pathology
To compare pharmacogenetic test predictions with self-reported treatment experience and side effect tolerability among patients with depression taking psychotherapeutic medications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom